These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6464744)

  • 41. Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening program.
    Waters DL; Dorney SF; Gaskin KJ; Gruca MA; O'Halloran M; Wilcken B
    N Engl J Med; 1990 Feb; 322(5):303-8. PubMed ID: 2296272
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Early detection of mucoviscidosis patients using trypsin RIA in dried blood stains].
    Luz O
    Padiatr Padol; 1987; 22(2):139-41. PubMed ID: 3614946
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunoreactive trypsin/DNA newborn screening for cystic fibrosis: should the R117H variant be included in CFTR mutation panels?
    Scotet V; Audrézet MP; Roussey M; Rault G; Dirou-Prigent A; Journel H; Moisan-Petit V; Storni V; Férec C
    Pediatrics; 2006 Nov; 118(5):e1523-9. PubMed ID: 17015492
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assay of serum immunoreactive trypsin in dried blood spots and the early detection of cystic fibrosis.
    Ryley HC; Robinson PG; Yamashiro Y; Bradley DM
    J Clin Pathol; 1981 Aug; 34(8):906-10. PubMed ID: 7276210
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Screening for cystic fibrosis by a stool trypsin method.
    Forrest DC; Wilcken B; Turner G
    Arch Dis Child; 1981 Feb; 56(2):151-3. PubMed ID: 7469468
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The neonatal detection of cystic fibrosis by measurement of immunoreactive trypsin in blood.
    Heeley AF; Bangert SK
    Ann Clin Biochem; 1992 Jul; 29 ( Pt 4)():361-76. PubMed ID: 1642442
    [No Abstract]   [Full Text] [Related]  

  • 47. [Mucoviscidosis screening with immunoreactive trypsin].
    Eber E; Ellemunter H; Engele H; Götz M; Grünberger W; Haas J; Janisch H; Leodolter S; Litscher H; Müller G
    Wien Klin Wochenschr; 1992; 104(22):681-5. PubMed ID: 1475973
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Determination of trypsin in dried blood for neonatal detection of cystic fibrosis].
    Travert G; Mustin C; Fernandez Y
    J Genet Hum; 1980 Dec; 28(4):141-4. PubMed ID: 7205198
    [No Abstract]   [Full Text] [Related]  

  • 49. Screening for cystic fibrosis.
    Ryley HC; Goodchild MC; Dodge JA
    Br Med Bull; 1992 Oct; 48(4):805-22. PubMed ID: 1458302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.
    Farrell PM; Kosorok MR; Laxova A; Shen G; Koscik RE; Bruns WT; Splaingard M; Mischler EH
    N Engl J Med; 1997 Oct; 337(14):963-9. PubMed ID: 9395429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cystic fibrosis identified by neonatal screening: incidence, genotype, and early natural history.
    Green MR; Weaver LT; Heeley AF; Nicholson K; Kuzemko JA; Barton DE; McMahon R; Payne SJ; Austin S; Yates JR
    Arch Dis Child; 1993 Apr; 68(4):464-7. PubMed ID: 8503667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Regional mucoviscidosis screening using immunoreactive trypsin in umbilical cord blood].
    Ploier R; Emhofer J; Licka B; Rezanka E; Turnher H
    Padiatr Padol; 1991; 26(6):263-6. PubMed ID: 1792095
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic delay in cystic fibrosis: lessons from newborn screening.
    Wilcken B; Towns SJ; Mellis CM
    Arch Dis Child; 1983 Nov; 58(11):863-6. PubMed ID: 6651321
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neonatal screening for cystic fibrosis: a comparison of two strategies for case detection in 1.2 million babies.
    Wilcken B; Wiley V; Sherry G; Bayliss U
    J Pediatr; 1995 Dec; 127(6):965-70. PubMed ID: 8523199
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening for cystic fibrosis.
    Heeley AF
    J Pediatr; 1983 Nov; 103(5):836. PubMed ID: 6631621
    [No Abstract]   [Full Text] [Related]  

  • 56. [Mucoviscidosis screening of newborn infants in the Dresden district. Results from 1 June 1996 to 31 March 2000].
    Wunderlich P; Stopsack M; Paul KD; Rösen-Wolff A
    Dtsch Med Wochenschr; 2000 Nov; 125(45):1356-60. PubMed ID: 11109423
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
    Comeau AM; Parad RB; Dorkin HL; Dovey M; Gerstle R; Haver K; Lapey A; O'Sullivan BP; Waltz DA; Zwerdling RG; Eaton RB
    Pediatrics; 2004 Jun; 113(6):1573-81. PubMed ID: 15173476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Reflections on the neonatal screening of mucoviscidosis].
    Farriaux JP; Gilly R; Navarro J; Roussel P; Travert G
    Arch Fr Pediatr; 1987; 44 Suppl 1():735-7. PubMed ID: 3329502
    [No Abstract]   [Full Text] [Related]  

  • 59. The role of the laboratory in the diagnosis of cystic fibrosis.
    Hjelm M; Davey J; Dinwiddie R; Jackson D; Quartey-Papafio P
    Clin Biochem; 1984 Oct; 17(5):284-7. PubMed ID: 6499156
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Neonatal screening of mucoviscidosis using radioimmunologic levels of trypsin in dried blood eluates].
    Bourguignon JP; Deby-Dupont G; Reuter A; Senterre J; Lambotte C; Gérard A; Franchimont P
    Rev Med Liege; 1984 May; 39(10):451-9. PubMed ID: 6463469
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.